High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. 1985

M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser

The risk of hereditary cutaneous malignant melanoma was evaluated in 401 members of 14 families with an autosomal dominant form of melanoma. We documented 127 primary melanomas in 69 family members, including 39 new melanomas diagnosed in 22 study participants from the time of first examination through a maximum of 8 years of follow-up. The 39 newly diagnosed melanomas occurred only in family members with dysplastic nevi, a known precursor of familial melanoma. Of 77 patients with dysplastic nevus syndrome without prior melanomas, 4 developed their first melanoma during prospective follow-up, as compared with 0.03 cases expected. The prospective age-adjusted incidence for melanoma was 14.3/1000 patients with dysplastic nevus per year, with a cumulative melanoma risk (+/- SE) of 7.2% (+/- 3.6) at 8 years. The actuarial probability of melanoma developing in family members with dysplastic nevi was 56.0% (+/- 10.1) from age 20 to age 59. This study confirms that dysplastic nevi are clinical markers of high risk for, and precursors of, hereditary melanoma.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D009508 Nevus, Pigmented A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi. Nevus, Melanocytic,Nevi, Melanocytic,Nevi, Pigmented,Pigmented Moles,Melanocytic Nevi,Melanocytic Nevus,Pigmented Nevi,Pigmented Nevus
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
October 1995, Journal of the American Academy of Dermatology,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
February 2014, The Journal of investigative dermatology,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
August 1990, American family physician,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
November 1991, The Journal of dermatology,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
August 1987, Lakartidningen,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
September 1994, Journal of the National Cancer Institute,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
September 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
January 1992, Texas medicine,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
January 1986, Przeglad dermatologiczny,
M H Greene, and W H Clark, and M A Tucker, and K H Kraemer, and D E Elder, and M C Fraser
June 2002, Cancer,
Copied contents to your clipboard!